Tag

V. Nagarajan & Co.

1 article

Emmessar Biotech FY26 Net Profit Rises 38% YoY

Board approved audited standalone financial results for FY26, reporting a net profit of ₹43.59 lakhs, a 38% increase year-on-year. Statutory auditors V. Nagarajan & Co. issued an unmodified audit opin